Apixaban Use in Patients with Protein C and S Deficiency: A Case Series and Review of Literature

BACKGROUND: Historically, warfarin was the mainstay anticoagulant agent to manage patients presenting with thrombotic disorders caused by Protein C or S deficiency. Several direct oral anticoagulants (DOACs) were introduced over the past decade. They showed superiority over warfarin in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Sulaiman, Khalid, Alsuwayyid, Faisal, Alrashidi, Abdulrahman, Alhijris, Mohammed, Almutairi, Faisal, Alharthi, Fahad, Abu Esba, Laila Carolina, Aljuhani, Ohoud, Badreldin, Hisham A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901412/
https://www.ncbi.nlm.nih.gov/pubmed/35264892
http://dx.doi.org/10.2147/JBM.S344083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901412/
https://www.ncbi.nlm.nih.gov/pubmed/35264892
http://dx.doi.org/10.2147/JBM.S344083

Ejemplares similares